Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults
NCT05799651
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
SARS-CoV-2
Interventions
BIOLOGICAL:
Glycovax-002
Sponsor
Glycovax Pharma Inc.
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]